Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Colonic Neoplasms 23Rectal Neoplasms 22Squamous Cell Carcinoma of Head and Neck 17Colorectal Neoplasms 13Salivary Gland Neoplasms 7Tongue Neoplasms 5Pancreatic Neoplasms 5Head and Neck Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Mouth Neoplasms 4Laryngeal Neoplasms 4Neoplasm Metastasis 3Lymphoid Interstitial Pneumonia 3Hypopharyngeal Neoplasms 3Carcinoma 3Oropharyngeal Neoplasms 2Esthesioneuroblastoma, Olfactory 2Carcinoma, Squamous Cell 2Adenocarcinoma of Lung 2Stomach Neoplasms 1Sarcoma 1Rhabdomyosarcoma 1Pleural Effusion, Malignant 1Pharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Locally Recurrent Skin Squamous Cell Carcinoma 1Gastrointestinal Stromal Tumors 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Radiotherapy 1Cisplatin 1Cetuximab 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Pharyngeal Neoplasms × Cetuximab × Clear all
NCT01445405 2019-12-17

Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
3 enrolled
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Pharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡